Incyte, Syndax Gets FDA Clearance for Niktimvo 9mg and 22mg Vials


Products or drugs approved by the FDA

Olivier Le Moal

Incentive (NASDAQ:INCY) and Syndax Pharmaceuticals (SNDX) have received FDA approval for their drug Niktimvo in 9 mg and 22 mg vial sizes.

Niktimvo was approved in August 2024 for the treatment of chronic graft-versus-host disease after failure of at least



Source link

  • Related Posts

    Many German companies want to raise prices, Ifo Ni Reuters said

    BERLIN (Reuters) – Germany’s Ifo price expectations index rose to its highest level since April 2023 in December, with all sectors of the economy contributing to the increase, the Ifo…

    Blue Origin’s new Glenn rocket takes off on first flight

    See what’s clicking on FoxBusiness.com. The Blue Origin of Jeff Bezos The rocket, New Glenn, successfully lifted off from Florida early Thursday after its first launch attempt was cleared on…

    Leave a Reply

    Your email address will not be published. Required fields are marked *